The Foundation Model, Soon to be Available on AWS Marketplace, Moves the Industry Beyond Drug Discovery, Ushering in a New Frontier for AI in Pharma Focused on Clinical Trials NEW YORK--(BUSINESS WIRE ...
The Company Has Established the Industry’s Most Advanced Portfolio of Clinical Trial Simulation Capabilities for ...
Clinical Trials Arena on MSN
The clinical trial supply model of the future
With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.
In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian approaches in modern drug development, emphasizing their potential to improve ...
In a remote, within-participant simulation, 26 oncologists from the United Kingdom, United States, Spain, and Singapore reviewed synthetic breast cancer cases and created comprehensive summaries for ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, discusses how growing FDA support is accelerating the adoption of Bayesian approaches, enabling more flexible, ...
Bayesian prediction and modeling have emerged as transformative tools in the design and management of clinical trials. By integrating prior knowledge with accumulating trial data, Bayesian methods ...
Consegna Pharma, Inc. ("Consegna" or the "Company") today announced that it has received written responses from the U.S. Food and Drug Administration (FDA) regarding its Type C meeting for CP217, the ...
This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...
Innovations in clinical trial designs and tools have the potential to unlock a new era of research that is more convenient for patients, more reflective of real-world treatment conditions, and more ...
The Company Has Established the Industry’s Most Advanced Portfolio of Clinical Trial Simulation Capabilities for Pharmaceutical and Biotechnology CompaniesTEL AVIV, Israel--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results